MENU
+Compare
AGEN
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$3.32
Change
-$0.13 (-3.77%)
Capitalization
78.39M

AGEN Agenus Forecast, Technical & Fundamental Analysis

a developer of technologies to treat cancers and infectious diseases

Industry Biotechnology
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for AGEN with price predictions
Feb 21, 2025

AGEN's RSI Indicator peaks and leaves overbought zone

The 10-day RSI Oscillator for AGEN moved out of overbought territory on January 22, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 instances where the indicator moved out of the overbought zone. In of the 27 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 19, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AGEN as a result. In of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AGEN turned negative on February 07, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AGEN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 70 cases where AGEN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

AGEN moved above its 50-day moving average on February 12, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for AGEN crossed bullishly above the 50-day moving average on January 16, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AGEN advanced for three days, in of 251 cases, the price rose further within the following month. The odds of a continued upward trend are .

AGEN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 108 cases where AGEN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AGEN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (12.496). P/E Ratio (0.455) is within average values for comparable stocks, (84.451). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). AGEN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.425) is also within normal values, averaging (251.218).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AGEN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

AGEN is expected to report earnings to rise 2,269.23% to -307 cents per share on May 09

Agenus AGEN Stock Earnings Reports
Q1'24
Est.
$-3.08
Q4'23
Missed
by $0.07
Q3'23
Beat
by $0.04
Q2'23
Est.
$-0.20
Q1'23
Missed
by $0.01
The last earnings report on March 14 showed earnings per share of -12 cents, missing the estimate of -5 cents. With 227.19K shares outstanding, the current market capitalization sits at 78.39M.
A.I. Advisor
published General Information

General Information

a developer of technologies to treat cancers and infectious diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3 Forbes Road
Phone
+1 781 674-4400
Employees
389
Web
https://www.agenusbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AZN74.220.71
+0.97%
AstraZeneca PLC
FUTU121.400.81
+0.67%
Futu Holdings Limited
ALNT26.59-0.28
-1.04%
Allient
HIMX10.63-0.62
-5.51%
Himax Technologies
PYXS1.28-0.08
-5.88%
Pyxis Oncology

AGEN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AGEN has been closely correlated with SNPX. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if AGEN jumps, then SNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGEN
1D Price
Change %
AGEN100%
-3.77%
SNPX - AGEN
91%
Closely correlated
+1.06%
ALLR - AGEN
87%
Closely correlated
+1.44%
NRXP - AGEN
83%
Closely correlated
-6.94%
PALI - AGEN
81%
Closely correlated
-3.76%
AXON - AGEN
42%
Loosely correlated
-5.28%
More

Groups containing AGEN

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGEN
1D Price
Change %
AGEN100%
-3.77%
AGEN
(5 stocks)
56%
Loosely correlated
-2.39%